Bernstein's Liang on China's Biotech Stock Rally
Biotech stocks in Hong Kong continue to rally amid hopes of AI-driven development. Bernstein senior analyst Rebecca Liang explains why investors are becoming more optimistic about biotech stocks than last year. She spoke on "Bloomberg: The China…
Read the full story at Bloomberg Markets ↗
ImpactNotable 35/100
Why it mattersRule-based estimate: no strong signals; trust 9/10.
RegionsGlobal
Published3 h ago (Wed, 30 Sep 2026 05:25:01 GMT)
RetrievedWed, 30 Sep 2026 07:00:50 GMT via rss
ClassifiedWed, 30 Sep 2026 07:01:06 GMT by heuristic